Alphatec Spine Adds Two Executives to Manufacturing and Legal Roles
BY EDITOR, NOVEMBER 18, 2005
Herbert Bellucci to be VP-Manufacturing, Ebun Garner to be VP-Legal
CARLSBAD, California, November 18, 2005 /PRNewswire/-- Alphatec Spine, Inc. ("Alphatec") today announced the appointments of two key executives, continuing the firm's remarkable growth from small contract medical device manufacturer to vertically-integrated spinal device company.
Herbert Bellucci was named Vice President, Manufacturing, and Ebun Garner was named VP of Legal Affairs and Compliance.
Ronald G. Hiscock, Chief Executive Officer, said, "I'm extremely pleased that Alphatec is attracting such top-tier talent. Both of these appointments helps give Alphatec the management it needs to continue its transition into one of the market's leading independent spinal device companies. In-house manufacturing is Alphatec's heritage and a competitive differentiator for us, and Herbert Bellucci's appointment signals our commitment to maintaining a world-class orthopedic device manufacturing operation. Ebun Garner will oversee our FDA approval and compliance programs, among other responsibilities, and his experience will play an essential part in our commercialization efforts."
Prior to joining Alphatec, Herbert Bellucci was most recently the Senior Vice President of Operations at Digirad Corp., where he oversaw Manufacturing, Customer Service, Quality, and Facilities. At Digirad, he relocated and consolidated the company's facilities, and oversaw a successful effort to receive ISO 13485 certification. Bellucci was previously Vice President of Manufacturing for Omnicell Inc., and Vice President of Operations for Vidamed Inc.
Ebun Garner has extensive merger and acquisition experience in the healthcare field, and a deep familiarity with drug discovery and development regulations. He was previously at New York law firms Mintz Levin Cohn Ferris Glovsky and Popeo, and Squadron, Ellenoff, Plesent & Sheinfeld.
About Alphatec Spine, Inc.
Alphatec Spine, Inc. is distinguished among independent spinal implant companies because it manufactures, engineers and prototypes all its own products. In 2005, the company changed its name from Alphatec Manufacturing to Alphatec Spine, to reflect its fifteen-year evolution from contract medical device manufacturer to vertically-integrated spinal device company. There are no service gaps between engineering and the physician. The Company has 165 employees and is located in Carlsbad, CA. In March 2005, the company was purchased by a group of investors led by the New York private equity firm HealthpointCapital LLC.
Additional Information
This press release contains certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty. Although Alphatec and HealthpointCapital believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. Important factors that could cause actual results to differ materially from the forward-looking statements include Alphatec's need to obtain additional capital (through financings or otherwise) to continue to grow its operations, the progress of development, government and regulatory approvals and commercialization of Alphatec's new technologies, and the market's acceptance of Alphatec's products. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by either Alphatec or HealthpointCapital or any other person that the objectives and plans of Alphatec will be achieved. By making these forward-looking statements, neither Alphatec nor HealthpointCapital undertakes an obligation to update these statements for revisions or changes after the date of this release.
CONTACT: Vicky Romanoski of Alphatec Spine, Inc. (760) 431-9286;
vromanoski@alphatecspine.com
Web site: http://www.alphatecspine.com
